FindTrial
Sign In

Withdraw due to duplicate registration. Associations of serum MMP-9 and BDNF with acute cerebral infarction: a longitudinal study

Associations of serum MMP-9 and BDNF with acute cerebral infarction: a longitudinal study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056226
Enrollment
Unknown
Registered
2022-02-01
Start date
2019-01-01
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute cerebral infarction

Interventions

the study group:MMP-9 and BDNF levels were measured

Sponsors

the First People Hospital of Zhaoqing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: i) patients meeting the diagnostic criteria for cerebral infarction revised at the Fourth National Conference on Cerebrovascular Disease and confirmed by cranial CT or MRI; ii) first onset; iii) patients were admitted to hospital within 24 hours.

Exclusion criteria

Exclusion criteria: patients with a history of tumor, severe infection, autoimmune disease or severe liver and kidney insufficiency.

Design outcomes

Primary

MeasureTime frame
concentration of MMP-9 and BDNF;Modified Rankin Scale;—

Countries

China

Contacts

Public ContactLI Youjia

the First People Hospital of Zhaoqing

lyj2102353@163.com+86 18902368836

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026